FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson ’s Disease and Drug-Induced Extrapyramidal Reactions

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC ( “Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) treatments utilizing its...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news